Stockreport

BridgeBio Pharma Announces Early Positive Data For BBP-812, Its Investigational AAV9 Gene Therapy For Canavan Disease [TheStreet.com]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF - These results are the first reported demonstration of rapid and robust treatment changes in key disease markers associated with the severity of disease - Initial phar [Read more]